Aldeyra Therapeutics (ALDX) Non-Current Debt (2013 - 2026)
Aldeyra Therapeutics (ALDX) reported Non-Current Debt of $15 million for Q1 2026, down 0.7% from $15.1 million a year earlier and unchanged from the prior quarter.
Powered by 
Analysis
Aldeyra Therapeutics (ALDX) Non-Current Debt (2013 - 2026) Analysis & Trends
Dating back to Q4 2013, Aldeyra Therapeutics' Non-Current Debt record includes 46 quarters.
- Non-Current Debt has a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
- By year, Non-Current Debt came in at $15 million in FY2024 (unchanged), $15 million in FY2023 (unchanged), $15 million in FY2022 (-3.2%) and $15.5 million in FY2021 (+3.4%).
- Five-year quarterly Non-Current Debt spans a low of $15 million in Q2 2022 and a high of $15.59 million in Q1 2022.
- Year over year, Non-Current Debt gained in 1 of the last six quarters, with an average year-over-year change of 0.0%.
- The high point for year-over-year Non-Current Debt in five years was Q1 2022 (growth of 3.9%); the low point was Q1 2023 (a decline of 3.8%).
- Per Business Quant data, the three quarters before Q1 2026 came in at $15 million (Q4 2025), $15 million (Q3 2025) and $15 million (Q2 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -108.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 51.86 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 23.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 60.50 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Aldeyra Therapeutics | 74.19 Mn | 74.19 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 15.00 Mn |
| Dec 31, 2025 | 15.00 Mn |
| Sep 30, 2025 | 15.00 Mn |
| Jun 30, 2025 | 15.00 Mn |
| Mar 31, 2025 | 15.10 Mn |
| Dec 31, 2024 | 15.00 Mn |
| Sep 30, 2024 | 15.00 Mn |
| Mar 31, 2024 | 15.00 Mn |
| Dec 31, 2023 | 15.00 Mn |
| Sep 30, 2023 | 15.00 Mn |
| Jun 30, 2023 | 15.00 Mn |
| Mar 31, 2023 | 15.00 Mn |
| Dec 31, 2022 | 15.00 Mn |
| Sep 30, 2022 | 15.00 Mn |
| Jun 30, 2022 | 15.00 Mn |
| Mar 31, 2022 | 15.59 Mn |
| Dec 31, 2021 | 15.50 Mn |
| Sep 30, 2021 | 15.42 Mn |
| Jun 30, 2021 | 15.34 Mn |
| Mar 31, 2021 | 15.00 Mn |
API Access
Aldeyra Therapeutics Non-Current Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-debt&ticker=ALDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-debt", "ticker": "ALDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-debt&ticker=ALDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();